Injectable long-acting naltrexone microparticle compositions
Abstract:
The present disclosure relates to naltrexone sustained release microparticle delivery systems for the treatment of diseases ameliorated by naltrexone. The injectable microparticle delivery system includes naltrexone encapsulated in biodegradable microparticles administered in a pharmaceutically acceptable vehicle.
Information query
Patent Agency Ranking
0/0